Early-Career Cancer Researchers named as Pew-Stewart Scholars

Navigate to:

Early-Career Cancer Researchers named as Pew-Stewart Scholars

PHILADELPHIA—The Pew Charitable Trusts and the Alexander and Margaret Stewart Trust announced today the newest class of Pew-Stewart scholars for cancer research.

Five standout scientists, nominated by the country’s leading cancer research institutions, will receive four years of flexible funding to pursue innovative work aimed at advancing progress toward a cure for cancer.

"This year’s impressive class of Pew-Stewart scholars is committed to excellence in every way," said Rebecca W. Rimel, Pew’s president and CEO. "They are determined to unlock the complex biological mysteries that make cancer such a devastating disease. We hope that their contributions to the cancer research landscape will echo for generations to come."

In 2014, Pew launched a partnership with the Stewart Trust—which has funded cancer researchers for more than 15 years—to begin supporting scientists trying to eradicate cancer. The 2015 Pew-Stewart scholars will pursue widely varied lines of inquiry in cancer biology, including the genetic basis of the disease, potential new therapeutics, and strategies that may bypass resistance to cancer-fighting drugs.

"The 2015 class of Pew-Stewart scholars is an exceptional group of outstanding young biomedical scientists, chosen by the committee with the expectation that they will be among the next generation’s leaders in cancer research," said Peter M. Howley, M.D., chair of the Pew-Stewart national advisory committee.

This year marks the 30th anniversary of Pew’s program to fund exceptional early-career researchers in the biomedical sciences—which, along with the Pew-Stewart program and the Pew Latin American fellows program, is designed to encourage informed risk-taking to bring about unexpected, powerful discoveries. The 2015 classes of Pew biomedical scholars and Latin American fellows were also announced today.

The 2015 Pew-Stewart scholars for cancer research are:

Mitchell Guttman, Ph.D.
California Institute of Technology
Biology

Min Yu, M.D., Ph.D.
University of Southern California
Biology and regenerative medicine

Adam de la Zerda, Ph.D.
Stanford University
Structural biology and electrical engineering

Trever Bivona, M.D., Ph.D.
University of California, San Francisco
Medicine and hematology/oncology

Cigall Kadoch, Ph.D.
Dana-Farber Cancer Institute, Harvard Medical School
Pediatric oncology, biological chemistry, and molecular pharmacology

Visit the program page to read the scholars’ full abstracts and learn more about the program.

###

The Pew Charitable Trusts is driven by the power of knowledge to solve today’s most challenging problems. Learn more at www.pewtrusts.org.

The Alexander and Margaret Stewart Trust, established in 1947, is a charitable foundation supporting nonprofit organizations that research, treat, and prevent cancer and pediatric illnesses. Learn more at www.stewart-trust.org.

America’s Overdose Crisis
America’s Overdose Crisis

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Quick View

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Stewart Scholars
Stewart Scholars
Project

Pew-Stewart Scholars for Cancer Research

Quick View
Project

The Pew-Stewart Scholars Program for Cancer Research is a national initiative designed to support promising early career scientists whose research will accelerate discovery and advance progress to a cure for cancer. The program—funded by The Alexander and Margaret Stewart Trust and administered by Pew—will support five investigators each year.

Composite image of modern city network communication concept

Learn the Basics of Broadband from Our Limited Series

Sign up for our four-week email course on Broadband Basics

Quick View

How does broadband internet reach our homes, phones, and tablets? What kind of infrastructure connects us all together? What are the major barriers to broadband access for American communities?

Pills illustration
Pills illustration

What Is Antibiotic Resistance—and How Can We Fight It?

Sign up for our four-week email series The Race Against Resistance.

Quick View

Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.